Medtronic Shares Decline Despite Beating Earnings Estimates Due to Disappointing Fiscal 2027 Outlook
Despite reporting better-than-expected Q4 earnings and revenue, Medtronic's shares fell in premarket trading due to a below-consensus fiscal 2027 profit outlook. The company projected adjusted EPS of $5.90-$6.00 for the year versus analyst estimates of around $6.06.
Tickers: $MDT
Topics: financial_guidance medical_devices stock_performance